Encouraging generic drug use has reduced health care costs for payers and consumers, but the availability of therapeutically interchangeable medications or generic medications of choice is not equal across disease states. The extent to which systems of care are able to substitute with generics is not well understood. Read more here. (Source: JMCP, November 2014).
You are here: / / Should There Be Risk Adjustment In Incentive Payments For The Use Of Generic Medications?